IDEXX Laboratories, Inc. (LON:0J8P)

Market Cap	31.02B
Revenue (ttm)	3.04B
Net Income (ttm)	692.69M
Shares Out	n/a
EPS (ttm)	8.37
PE Ratio	44.78
Forward PE	40.50
Dividend	n/a
Ex-Dividend Date	n/a

Volume	481
Average Volume	254
Open	505.00
Previous Close	493.55
Day's Range	496.84 - 507.94
52-Week Range	373.77 - 583.30
Beta	1.53
RSI	78.67
Earnings Date	May 1, 2025

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1983
• Employees: 11,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0J8P

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Financial numbers in USD